Basic universal healthcare, the growth of medical tourism, and foreign investment incentives schemes introduced by the Thai Board of Investment (BOI) have each contributed to the growth of Thailand’s healthcare and pharmaceutical sectors.
The Thai Food and Drug Administration’s (TFDA’s) recent membership in the Pharmaceutical Inspection Co-Operation Scheme (PIC/S) also presents growth opportunities to pharmaceutical manufacturers and distributors in Thailand by improving export access to ASEAN member states.
However, if not regulatory-ready, healthcare and pharmaceutical companies entering the Thai market may encounter regulatory and compliance challenges as the industry is regulated by a broad framework of legislation and regulations. As healthcare and pharmaceutical companies constantly innovate and evolve, regulatory policymaking may also impact on their businesses.
Siam Premier understands the healthcare and pharmaceutical industry and makes sense of its complex legal framework. We assist global pharmaceutical companies implement their Thai market entry strategy, working closely with them to set up the right corporate structure and establish robust operations within the regulatory framework. We also advise pharmaceutical companies on matters affecting their day-to-day operations including in relation to R&D, clinical trials, manufacturing, employment and labour, environment, labeling, advertising, and sales of pharmaceuticals. And, when they are looking to invest or divest, our corporate / M&A team assists them to execute their domestic and cross-border M&A strategies.
We have experience in advising some of the world’s largest pharmaceutical companies on sensitive and complex regulatory and contentious intellectual property matters in Thailand, including regarding the imposition of compulsory licenses for certain patented pharmaceuticals.
In the Healthcare sector, we advise hospital groups and clinics on corporate and regulatory matters affecting their operations, including in relation to licensing and permits.
Our expertise in the Healthcare and Pharmaceutical sectors includes advising on: